Nootropics News Hubb
Advertisement Banner
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact
No Result
View All Result
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home Neuroscience

Teaching Video NeuroImage: Dural Angioleiomyoma

admin by admin
October 31, 2023
in Neuroscience


A 47-year-old man with an unremarkable medical history presented with mild dull occipital headaches for 7 months, without other neurologic changes. Structural MRI showed an extraparenchymal, well-delineated left cerebellar lesion with partial postgadolinium enhancement (Figure). Exploration with T1-weighted perfusion (Video 1) revealed a progressive, centrifugal enhancement pattern with slow contrast filling, rapid near the center but slower toward outer edges, suggesting a benign mesenchymal tumor. The absence of mass effect and cerebellar symptoms further supported a slow-growing tumor. A surgical removal was performed. Neuropathologic examination revealed a well-circumscribed lesion with smooth muscle cells and vascular cavities, indicating dural angioleiomyoma (Figure). Dural angioleiomyoma is a rare benign tumor, with <80 cases reported in a recent literature review1 related to soft tissue angioleiomyomas. Partial and flame-like enhancement arising from the tumor base and extending to its periphery seems to be the most typical imaging characteristic,2 and dynamic contrast-enhanced sequence may aid in envisioning diagnosis preoperatively.

Figure MRI and Neuropathology

MRI: coronal T2 fluid-attenuated inversion recovery (A) and contrast-enhanced T1-weighted sagittal (B) views. Neuropathology: anfractuous vascular cavities separated by muscular walls (Hematoxylin-Phloxin-Saffron) (C). Immunohistochemical analysis: smooth muscle cells labeled with antiactin antibodies (D).

Author Contributions

T. Leclerc: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data; study concept or design; analysis or interpretation of data. C. Oppenheim: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data; study concept or design; analysis or interpretation of data. A. Tauziede-Espariat: major role in the acquisition of data; analysis or interpretation of data. Hélène Charpentier: major role in the acquisition of data. J. Pallud: major role in the acquisition of data; analysis or interpretation of data. J. Benzakoun: drafting/revision of the manuscript for content, including medical writing for content; major role in the acquisition of data; study concept or design; analysis or interpretation of data.

Study Funding

No targeted funding reported.

Disclosure

The authors report no relevant disclosures. Go to Neurology.org/N for full disclosures.

Footnotes

  • Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.

  • Submitted and externally peer reviewed. The handling editor was Resident & Fellow Section Editor Whitley Aamodt, MD, MPH.

  • Received May 4, 2023.
  • Accepted in final form July 6, 2023.
  • © 2023 American Academy of Neurology



Source link

Previous Post

Recognition of motor intentions from EEGs of the same upper limb by signal traceability and Riemannian geometry features

Next Post

19 Signs a Taurus Man Thinks You’re the One

Next Post

19 Signs a Taurus Man Thinks You're the One

Recommended

Q&A: Lexie Phillips, Jack Daniel’s First Female Assistant Distiller

3 months ago

Short-term Trajectories of Poststroke Cognitive Function

6 months ago

Quality control practices in FMRI analysis: Philosophy, methods and examples using AFNI

10 months ago

Clinical and Neurophysiologic Phenotypes in Neonates With BRAT1 Encephalopathy

9 months ago

15 Must-Know Signs of an Insecure Woman

11 months ago

301 Best Favorite Things Questions

4 months ago

© Nootropics News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact

© 2022 Nootropics News Hubb All rights reserved.